Custom Health, a comprehensive technology-enabled medication management and managed care solution provider, agreed to go public via a SPAC merger with Berenson Acquisition I, a special purpose acquisition corporation, in a $185m deal. "We are very excited to work closely with the BACA team to transform the care experience for people at home. We believe that their deep mergers and acquisitions expertise coupled with our shared commitment to impact patient lives will accelerate our path to market. Guessing with medication must stop. We have the expertise, technology and comprehensive data to help people who take medication achieve the best possible health outcome," Shane Bishop, Custom Health CEO.